
from
TF Market Research34 page report
published Jan 29, 2007
Price
$1,360.00 available for immediate download

This report is also available for purchase on a
per-page basis.
Report Overview
Purchase by Section
Search Inside
...Impax Laboratories, Inc. engages in the development, manufacture, and marketing of specialty prescription pharmaceutical products utilizing its own formulation expertise and drug delivery technologies. As of March #, ####, the company had approximately ## generic products approved or pending approval, or under development, which consisted of ## abbreviated new drug applications (ANDAs) approved by the FDA, which include generic versions of brand name pharmaceuticals, such as Brethine, Florinef, Minocin, Claritin -D ## -hour, Claritin -D ## -hour, Wellbutrin SR, and Prilosec; ## applications pending at the FDA, including generic versions of OxyContin, Allegra D, and Tricor; and ## other products in various stages of development, which are for generic versions of brand name pharmaceuticals. The company sells its products to large pharmaceutical wholesalers, warehousing chain drug stores, mass merchandisers, and mail -order pharmacies through strategic alliances and the company...
Source: LIFE SCIENCE ANALYTICS
Company: IMPAX LABORATORIES INC
Geographic Regions: CALIFORNIA (STATE OF), NORTH AMERICA, PACIFIC STATES REGION, UNITED STATES OF AMERICA
TF Market ResearchTF Market Research® reports contain in-depth primary research and statistics, market trends, forecasts, segment analysis and much more from over 100 top consulting, market research and business publishing sources. The service is updated daily.